Localization of vascular endothelial growth factor in nontumorous human pituitaries

Endocrine Pathology

Volumn 10, Issue 2, 1999, Pages 109-122

  Vidal, Sergio ^a   Kovacs, Kalman ^a   Cohen, Sandra M ^a   Stefaneanu, Lucia ^a   Lloyd, Ricardo V ^b   Scheithauer, Bernd W ^b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b MAYO CLINIC   (United States)

Author keywords

Immunohistochemistry; In situ hybridization; Pituitary; Vascular endothelial growth factor

Indexed keywords

GROWTH HORMONE; PROTEIN S 100; VASCULOTROPIN;

ADULT; ARTICLE; CELL TYPE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; HUMAN; HUMAN TISSUE; HYPOPHYSIS; IMMUNOCYTOCHEMISTRY; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL;

EID: 0032788046     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02739823     Document Type: Article

References (42)

1. Risau W. Mechanisms of angiogenesis. Nature 386:671-674, 1997.
2. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 18:4-25, 1997.
3. Folkman J, Shing Y. Angiogenesis. J Biol Chem 267:10,931-10,934, 1992.
4. Klagsbrun M, D'Amore PA. Regulators of angiogenesis. Annu Rev Physiol 53:217-239, 1991
5. Ferrara N, Houck K, Jakeman L, Leung D. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18-32, 1992.
6. Conn G, Bayne M, Soderman L, Kwok PW, Sullivan KA, Palisi TM, et al. Amino acid and cDNA sequence of a vascular endothelial cell mitogen homologous to platelet-derived growth factor. Proc Natl Acad Sci USA 87:2628-2632, 1990.
7. Keck PJ, Hauser SD, Krivi G, Sanzo K, Warren T, Feder J, Connolly DT. Vascular permeability factor, an endothelial cell mitogen related to platelet derived growth factor. Science 246:1309-1312, 1989.
8. Leung DW, Cachaianes G, Kuang WJ, Goaddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309, 1989.
9. Plouet J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT20 cells. EMBO J 8:3801-3806, 1989.
10. Connolly DT, Olander JV, Heuvelman D, Nelson R, Monsell R, Siegel N, et al. Human vascular permeability factor. Isolation from U937 cells. J Biol Chem 254:20,017-20,024, 1989.
11. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219:983-985, 1983.
12. Scheithauer BW, Sano T, Kovacs K, Young WF, Ryan N, Randall RV. The pituitary gland in pregnancy: A clinicopathologic and immunohistochemical study of 69 cases. Mayo Clin Proc 65:461-474, 1990.
13. Khalil A, Kovacs K, Sima AAF, Burrow GN, Horvath E. Pituitary thyrotroph hyperplasia mimicking prolactin-secretion adenoma. J Endocrinol Invest 7:399-404, 1984.
14. Sano T, Asa SL, Kovacs K. Growth hormone-releasing hormone-producing tumors: Clinical, biochemical, and morphological manifestations. Endocr Rev 9:357-373, 1988.
15. Elias K, Weiner R. Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors. Proc Natl Acad Sci USA 81:4549-4553, 1984.
16. Banerjee SK, Sarkar DK, Weston AP, De A, Campbell DR. Overexpression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis. Carcinogenesis 18:1155-1161, 1997
17. Erroi A, Bassetti M, Spada A, Giannattasio G. Microvasculature of human micro- and macroprolactinomas. A morphological study. Neuroendocrinology 43:159-165, 1986.
18. Jugenburg M, Kovacs K, Stefaneanu L, Scheithauer BW. Vasculature in nontumorous hypophysis, pituitary adenomas, and carcinomas: A quantitative morphologic study. Endocr Pathol 6:115-124, 1995.
19. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577-580, 1981.
20. Kovacs K, Lloyd RV, Horvath E, Asa SL, Stefaneanu L, Killinger DW, et al. Silent somatotroph adenomas of the human pituitary: A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization. Am J Pathol 134:345-353, 1989.
21. Kovacs K, Stefaneanu L, Horvath E, Lloyd RV, Lancranjan I, Buchfelder M, et al. Effects of dopamine agonist medication on prolactin producing pituitary adenomas: A morphologic study including immunocytochemistry, electron microscopy and in situ hybridization. Virchow Arch A: Pathol Anat 418:439-446, 1991.
22. Bendayan M. Double immunocytochemical labeling applying the protein A-gold technique. J Histochem Cytochem 30:81-85, 1982.
23. Bendayan M, Zollinger M. Ultrastructural localization of antigenic sites on fixed tissues applying the protein A-gold technique. J Histochem Cytochem 31:101-109, 1983.
24. Lloyd RV, Jin L, Qian X, Scheithauer BW, Young WF Jr, Davis DH. Analysis of the chromogranin A post-translational product pancreastatin and the prohormone convertases PC2 and PC3 in normal and neoplastic human pituitaries. Am J Pathol 146;1188-1198, 1995
25. Berkman RA, Merrill MJ, Reinhold WC, Munacci WT, Saxena A, Clark WC, et al. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasm. J Clin Invest 91:153-159, 1993.
26. Ray D, Melmed S. Pituitary cytokine and growth factor expression and action. Endocr Rev 18:206-228, 1997.
27. Renner U, Pagotto U, Arzt E, Stalla GK. Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: A review. Eur J Endocrinol 135:515-532, 1996.
28. Jabbour HN, Boddy SC, Lincoln GA. Pattern and localization of expression of vascular endothelial growth factor and its receptor flt-1 in the ovine pituitary gland; expression is independent of hypothalamic control. Mol Cell Endocrinol 134:91-100, 1997.
29. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 161:851-858, 1989.
30. Ferrara N, Leung DW, Cachianes G, Winer J, Henzel WJ. Purification and cloning of vascular endothelial growth factor secreted by folliculo-stellate cells. Methods Enzymol 198:391-405, 1991.
31. Perryman EK. Folliculo-stellate cells of the pituitary gland. Bioscience 39:81-88, 1989.
32. Baird A, Esch F, Mormede P, Ueno N, Ling N, Bohlem P, et al. Molecular characterization of fibroblast growth factor: Distribution and biological activities in various tissues. Recent Prog Horm Res 42:143-201, 1986.
33. Schechter J, Weiner R. Changes in basic fibroblast growth factor coincident with estradiol-induced hyperplasia of the anterior pituitaries of Fisher 344 and Sprague-Dawley rats. Endocrinology 129:2400-2408, 1991.
34. Groth C, Unsicker K. Immunocytochemical localization of basic fibroblast growth factor in bovine adrenal gland, ovary, and pituitary. J Histochem Cytochem 37:1877-1883, 1989.
35. Jin L, Chandler WF, Lloyd R. Localization of basic fibroblast growth factor (bFGF) protein and mRNA in human pituitaries: Regulation of bFGF mRNA by gonadotropin-releasing hormone. Endocr Pathol 5:27-34, 1994
36. Marin F, Boya J. Immunocytochemical localization of basic fibroblast growth factor in the human pituitary gland. Neuroendocrinology 62:523-529, 1995.
37. Pepper MS, Ferrara N, Orci I., Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189:824-831, 1992.
38. Seghezzi G, Patel S, Ren CJ, Gualandris A, Pintucci G, Robbins ES, et al. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis. J Cell Biol 141:1659-1673, 1998.
39. Ezzat S, Smyth HS, Ramyar L, Asa SL. Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas. J Clin Endocrinol Metab 80:878-885, 1995.
40. Silverlight JJ, Prysor-Jones RA, Jenkins JS. Basic fibroblast growth factor in human pituitary tumors. Clin Endocrinol 32:669-676, 1990.
41. Vidal S, Stefaneanu L, Kovacs K, Scheithauer BW. Expression of von Hippel-Lindau protein (VHL-P) in nontumorous and adenomatous human pituitaries. Pituitary, in press.
42. Mukhopadhyay D, Knebelmann B, Cohen HT, Ananth S, Sukhatme VP. The von Hippel-Lindau (VHL) tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor (VEGF) promoter activity. Mol Cell Biol 17:5629-5639, 1997.